List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 58 studies with search of:   Tunisia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer
Intervention: Drug: Dutasteride
2 Completed Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults
Condition: Diarrhea
Intervention: Drug: Diosmectite (Smecta®)
3 Recruiting Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer
Interventions: Drug: pazopanib (GW786034);   Drug: lapatinib (Tykerb)
4 Completed Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation
Condition: Induced Abortion
Intervention: Drug: Mifepristone, misoprostol
5 Recruiting Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate MDI (MF MDI);   Drug: Formoterol MDI;   Drug: Placebo
6 Recruiting LENS - Long-Term Eltrombopag Observational Study
Condition: Ocular Safety
Intervention: Drug: Observational Study
7 Completed SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Immune Thrombocytopenic Purpura
Intervention: Drug: SB497115
8 Completed Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
Condition: Breast Cancer
Intervention: Drug: lapatinib
9 Recruiting Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Condition: Advanced Renal Cell Carcinoma
Intervention: Drug: pazopanib
10 Recruiting EXTEND (Eltrombopag Extended Dosing Study)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: eltrombopag olamine (SB-497115-GR)
11 Active, not recruiting GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Drug: Pazopanib or placebo
12 Completed Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer
Conditions: Breast Cancer;   Newly Diagnosed;   ErbB2 Overexpressing;   ErbB1 Expressing;   Inflammatory
Interventions: Drug: Lapatinib;   Drug: Paclitaxel
13 Completed Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
14 Active, not recruiting Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer;   Advanced Breast Cancer
Interventions: Drug: Letrozole;   Drug: Lapatinib (GW572016)
15 Recruiting Efficacy and Safety of Colloids Versus Crystalloids for Fluid Resuscitation in Critically Ill Patients
Condition: Critical Illness
Interventions: Drug: Crystalloids;   Drug: Colloids;   Drug: Crystalloids;   Drug: Colloids
16 Enrolling by invitation Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Condition: Epilepsy, Partial
Intervention: Drug: Brivaracetam (ucb 34714)
17 Completed Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Conditions: Hypertension;   Hyperlipidemia
Intervention: Drug: Amlodipine/atorvastatin single pill
18 Completed Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia
Condition: Inflammatory Breast Cancer
Intervention:
19 Recruiting GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: AVE0010;   Drug: Placebo
20 Recruiting Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
Condition: Hypertension
Interventions: Drug: Irbesartan/hydrochlorothiazide;   Drug: Valsartan/hydrochlorothiazide;   Drug: Hydrochlorothiazide

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services